Krishna Institute of Medical Sciences · risk themes across the available quarters.
Bear-case history
Nasik hospital ramp-up has been slow due to delayed insurance and corporate empanelment (accounts for 60% of volumes in Maharashtra cluster). Similar 9-12 month delays expected for Bangalore launch. Patients are choosing alternative hospitals rather than navigate cumbersome reimbursement processes.
Nasik has 2-3 specialties still pending doctor onboarding, contingent on insurance empanelment completion. This creates a chicken-and-egg problem where insurance is needed to attract specialists, but specialists are needed to qualify for insurance.
Company is in aggressive expansion mode with 5 new hospitals simultaneously ramping. EBITDA margin compressed to 22.7% vs 26.6% year-ago. Management deflected when asked for peak revenue potential and steady-state ROC targets by cluster, providing only directional guidance.
AP cluster margins impacted in Q1 due to doctor onboarding costs at Kolar (commissioned July 1) and renovation delays at QNR acquired hospital. Renovation completion and subsequent ramp-up delayed into Q2-Q3.
Nashik (commissioned January 2025) is still incurring losses primarily because the 172B license required for CGHS business (35-40% of local hospital market) has not been obtained. This is also preventing doctor onboarding as specialists are reluctant to join without corporate/payer access. Management expects license in 'next few months'.
Thane currently has only one insurance empanelment; target is top-5 insurers by Q4. Nashik just completed 2 of 5 empanelments. This delays revenue ramp in insurance-heavy markets (Nashik, Thane, Bangalore) as cash patients alone represent only 30% of typical hospital revenues.
The flagship Telangana hospital has ~300 beds currently non-functional due to ongoing rehabilitation. Coupled with occupancy in low-50s and mature cluster dynamics, management guides only high single-digit growth for this largest cluster until Kundapur commissioning in Q1 FY27.
Analyst raised concerns about presence of Manipal, Narayana, Jupiter and other established players in Bangalore. Management acknowledges competition but emphasizes focus on currently underserved micro-markets where Mahadevara and Electronic City facilities are being positioned at affordable pricing. Actual market acceptance remains to be validated.
Seven hospitals commissioned in 2025 are creating EBITDA erosion as they ramp up. Management acknowledges this drag on margins, with EBITDA declining 2.2% YoY and margins compressing to 20.4% versus 25.9% in Q3 FY25.
Nashik and Thane units face 30% revenue exposure to insurance which is delayed. Only 2 of top-5 insurers empaneled so far; remaining 3 targeted for completion by Q4 FY26. Analyst questioned why negotiations took longer than anticipated.
Andhra cluster experienced 45-60 day disruption due to state government strike on ROG payments, causing significant volume dip. Payer mix contribution from state government declining as expansion moves to other states.
Telangana cluster running at 52.5% occupancy but 200-250 beds under renovation (85% on available beds). Management guided only high single-digit growth for mature Telangana cluster, with double-digit contingent on new facility additions.
GIC's common empanelment initiative created confusion and significantly delayed insurance approvals for new hospitals. Nasik still awaiting Star and Ayushman; Bangalore insurance may take 3-4 more months. This has directly impacted revenue ramp-up for new units.
Company expects continued EBITDA drag from new units in FY27 despite gradual narrowing of losses. Management declined to quantify expected losses for FY27-28, indicating uncertainty about the trajectory.
The planned June 2026 transition from old 200-bed facility to new 800-bed facility involves operational disruption. Old facility may run for 2-3 months post-transition, potentially causing temporary margin pressure and patient transition challenges.
When pressed on common empanelment initiative legality and pricing concerns raised by peers, management declined to comment stating 'I don't think it's appropriate to comment on that now.' This leaves uncertainty around potential pricing pressure if common empanelment becomes mandatory.